Search
A global-first innovation, developed by a research team at Kingston Health Sciences Centre (KHSC) and Queen’s University, is changing the way scientists study glioblastoma, the most aggressive form of brain cancer.
In just over a month, Kingston Health Sciences Centre will be welcoming about 130 new medical residents. Once they arrive, they will be spending the next several years with us, completing their training to become full physicians while helping care...
In a Canadian first, a hybrid cardiac ablation procedure has been successfully completed at Kingston Health Sciences Centre (KHSC). The procedure is a revolutionary treatment for patients who suffer from atrial fibrillation - the most common type of...
Nurturing her passion for caring, leading and learning, Dr. Donatella Tampieri with the KHSC Department of Diagnostic Radiology has improved patient outcomes by providing innovative services closer to home for patients living with a brain aneurysm...
Members of our Board of Directors got a special behind-the-scenes look at Kingston General Hospital in action last week. As part of a two-day orientation and education session, the board members met with staff, went on tours and took in presentations...
It's almost showtime for our 2nd annual Kingston General Hospital Community Showcase. It runs this year from Monday, Jan. 20 to Friday, Jan. 24. The Showcase will feature an event or two each day, all aimed at promoting interprofessional education an...
Kingston General Hospital, (KGH) the first hospital in Canada to complete a blue light cystoscopy outside of a clinical trial, will soon begin offering the procedure on regular basis to improve the quality of life for patients living with bladder...
Dr. Susan Bartels, a global health specialist at the KGH Research Institute, recently returned from Lebanon where she and a team are working to address a world health crisis - child marriage. The flow of Syrian refugees into countries including...
Kingston Health Sciences Centre (KHSC) recently hosted a group of physicians from South America who came to learn about the technology and methods we have in place for our complex cardiac cases. This international training session was the first of...
For the first time ever, researchers are studying the home use of non-hallucinogenic/micro-dose levels of psilocybin — the active compound found in psychedelic mushrooms — to treat Generalized Anxiety Disorder (GAD).
